{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:42:03Z","timestamp":1774680123055,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovative Research Program for Graduates of Institute of Hubei University of Medicine","award":["JC2020003, JC202109, YC2023033,  YC2024007"],"award-info":[{"award-number":["JC2020003, JC202109, YC2023033,  YC2024007"]}]},{"name":"Innovative Research Program for Graduates of Institute of Hubei University of Medicine","award":["JC2020003, JC202109, YC2023033,  YC2024007"],"award-info":[{"award-number":["JC2020003, JC202109, YC2023033,  YC2024007"]}]},{"name":"Innovative Research Program for Graduates of Institute of Hubei University of Medicine","award":["JC2020003, JC202109, YC2023033,  YC2024007"],"award-info":[{"award-number":["JC2020003, JC202109, YC2023033,  YC2024007"]}]},{"name":"Innovative Research Program for Graduates of Institute of Hubei University of Medicine","award":["JC2020003, JC202109, YC2023033,  YC2024007"],"award-info":[{"award-number":["JC2020003, JC202109, YC2023033,  YC2024007"]}]},{"name":"the Hubei Provincial Natural Science Foundation","award":["2023AFB882, 2022CFB004"],"award-info":[{"award-number":["2023AFB882, 2022CFB004"]}]},{"name":"the Hubei Provincial Natural Science Foundation","award":["2023AFB882, 2022CFB004"],"award-info":[{"award-number":["2023AFB882, 2022CFB004"]}]},{"name":"the Provincial Training Program of Innovation and Entrepreneurship for undergraduates","award":["S202110929011"],"award-info":[{"award-number":["S202110929011"]}]},{"name":"the Natural Science Foundation of Hubei Provincial Department of Education","award":["Q20212103"],"award-info":[{"award-number":["Q20212103"]}]},{"name":"the Natural Science Foundation of Hubei Provincial Department of Education","award":["Q20212103"],"award-info":[{"award-number":["Q20212103"]}]},{"name":"Cultivating Project for Young Scholar at Hubei University of Medicine","award":["2020QDJZR018"],"award-info":[{"award-number":["2020QDJZR018"]}]},{"name":"Free Exploration Project of Hubei University of Medicine","award":["FDFR201901"],"award-info":[{"award-number":["FDFR201901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12781-x","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:02:19Z","timestamp":1724655739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TSA attenuates the progression of c-Myc-driven hepatocarcinogenesis by pAKT-ADH4 pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenpeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"issue":"1","key":"12781_CR1","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10(1):3499.","journal-title":"Nat Commun"},{"issue":"2","key":"12781_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250\u201361.","journal-title":"J Hepatol"},{"issue":"8","key":"12781_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","volume":"81","author":"L Bi","year":"2021","unstructured":"Bi L, Ren Y, Feng M, Meng P, Wang Q, Chen W, et al. HDAC11 regulates Glycolysis through the LKB1\/AMPK Signaling Pathway to maintain Hepatocellular Carcinoma Stemness. Cancer Res. 2021;81(8):2015\u201328.","journal-title":"Cancer Res"},{"key":"12781_CR4","doi-asserted-by":"publisher","first-page":"119504","DOI":"10.1016\/j.lfs.2021.119504","volume":"277","author":"MJ Ramaiah","year":"2021","unstructured":"Ramaiah MJ, Tangutur AD, Manyam RR. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci. 2021;277:119504.","journal-title":"Life Sci"},{"issue":"42","key":"12781_CR5","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.2174\/0929867327666200102115720","volume":"27","author":"Y Ling","year":"2020","unstructured":"Ling Y, Liu J, Qian J, Meng C, Guo J, Gao W, et al. Recent advances in multi-target drugs targeting protein kinases and histone deacetylases in Cancer Therapy. Curr Med Chem. 2020;27(42):7264\u201388.","journal-title":"Curr Med Chem"},{"issue":"36","key":"12781_CR6","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.2174\/0929867326666190712160842","volume":"27","author":"D Schizas","year":"2020","unstructured":"Schizas D, Mastoraki A, Naar L, Tsilimigras DI, Katsaros I, Fragkiadaki V, et al. Histone Deacetylases (HDACs) in gastric Cancer: an update of their emerging prognostic and therapeutic role. Curr Med Chem. 2020;27(36):6099\u2013111.","journal-title":"Curr Med Chem"},{"issue":"41","key":"12781_CR7","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.3748\/wjg.v24.i41.4635","volume":"24","author":"D Schizas","year":"2018","unstructured":"Schizas D, Mastoraki A, Naar L, Spartalis E, Tsilimigras DI, Karachaliou GS, et al. Concept of histone deacetylases in cancer: reflections on esophageal carcinogenesis and treatment. World J Gastroenterol. 2018;24(41):4635\u201342.","journal-title":"World J Gastroenterol"},{"key":"12781_CR8","doi-asserted-by":"publisher","first-page":"1164514","DOI":"10.3389\/fimmu.2023.1164514","volume":"14","author":"B Lian","year":"2023","unstructured":"Lian B, Chen X, Shen K. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer. Front Immunol. 2023;14:1164514.","journal-title":"Front Immunol"},{"issue":"5","key":"12781_CR9","first-page":"349","volume":"14","author":"S Shin","year":"2017","unstructured":"Shin S, Kim M, Lee SJ, Park KS, Lee CH. Trichostatin A sensitizes Hepatocellular Carcinoma cells to enhanced NK Cell-mediated killing by regulating Immune-related genes. Cancer Genomics Proteom. 2017;14(5):349\u201362.","journal-title":"Cancer Genomics Proteom"},{"key":"12781_CR10","doi-asserted-by":"crossref","unstructured":"Algaissi A, Tabassum H, Khan E, Dwivedi S, Lohani M, Khamjan NA, et al. HDAC inhibition by Nigella sativa L. sprouts extract in hepatocellular carcinoma: an approach to study anti-cancer potential. J Biomol Struct Dyn. 2023 Nov;10:1\u201319.","DOI":"10.1080\/07391102.2023.2279283"},{"key":"12781_CR11","doi-asserted-by":"crossref","unstructured":"Freese K, Seitz T, Dietrich P, Lee SML, Thasler WE, Bosserhoff A et al. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Cancers (Basel). 2019 Oct 18, 11(10):1587.","DOI":"10.3390\/cancers11101587"},{"issue":"4","key":"12781_CR12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s12032-011-0126-3","volume":"29","author":"RR Wei","year":"2012","unstructured":"Wei RR, Zhang MY, Rao HL, Pu HY, Zhang HZ, Wang HY. Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma. Med Oncol. 2012;29(4):2737\u201343.","journal-title":"Med Oncol"},{"issue":"4","key":"12781_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen X, Calvisi DF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol. 2014;184(4):912\u201323.","journal-title":"Am J Pathol"},{"key":"12781_CR14","doi-asserted-by":"crossref","unstructured":"Tenen DG, Chai L, Tan JL. Metabolic alterations and vulnerabilities in hepatocellular carcinoma. Gastroenterol Rep (Oxf) 2021, 9(1):1\u201313.","DOI":"10.1093\/gastro\/goaa066"},{"key":"12781_CR15","doi-asserted-by":"crossref","unstructured":"Mendivil-Alvarado JD-V, Coronado-Alvarado H, Astiazaran-Garcia CD. H. Extracellular Vesicles from Adipose Tissue Could Promote Metabolic Adaptation through PI3K\/Akt\/mTOR. Cells 2022, 11(11).","DOI":"10.3390\/cells11111831"},{"key":"12781_CR16","doi-asserted-by":"crossref","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in Cancer therapeutics: are we making Headway? Front Oncol 2022, 12:819128.","DOI":"10.3389\/fonc.2022.819128"},{"key":"12781_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"12781_CR18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/jpm12111788","volume":"12","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Ricci AD, Brandi G. Trans-arterial chemoembolization plus systemic treatments for Hepatocellular Carcinoma: an update. J Pers Med. 2022;12(11):1788.","journal-title":"J Pers Med"},{"issue":"1","key":"12781_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Jin T, Zhu Y, Dai C. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018;37(1):110.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"12781_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Santoni M, Mollica V, Logullo F, Rosellini M, Marchetti A, et al. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021;17(12):1455\u201366.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"12781_CR21","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/cancers16101835","volume":"16","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Rizzo A, Aksoy S, Guven DC. Prognostic significance of the Royal Marsden Hospital (RMH) score in patients with Cancer: a systematic review and Meta-analysis. Cancers (Basel). 2024;16(10):1835.","journal-title":"Cancers (Basel)"},{"key":"12781_CR22","doi-asserted-by":"publisher","first-page":"1039121","DOI":"10.3389\/fmolb.2022.1039121","volume":"9","author":"DC Guven","year":"2022","unstructured":"Guven DC, Sahin TK, Erul E, Rizzo A, Ricci AD, Aksoy S, et al. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Mol Biosci. 2022;9:1039121.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"12781_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00262-023-03366-x","volume":"72","author":"A Rizzo","year":"2023","unstructured":"Rizzo A, Mollica V, Tateo V, Tassinari E, Marchetti A, Rosellini M, et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study. Cancer Immunol Immunother. 2023;72(6):1381\u201394.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"12781_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hep.29183","volume":"66","author":"P Liu","year":"2017","unstructured":"Liu P, Ge M, Hu J, Li X, Che L, Sun K, et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Hepatology. 2017;66(1):167\u201381.","journal-title":"Hepatology"},{"key":"12781_CR25","doi-asserted-by":"crossref","unstructured":"Xia JK, Qin XQ, Zhang L, Liu SJ, Shi XL, Ren HZ. Roles and regulation of histone acetylation in hepatocellular carcinoma. Front Genet 2022, 13:982222.","DOI":"10.3389\/fgene.2022.982222"},{"key":"12781_CR26","doi-asserted-by":"crossref","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J. Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 2017, 18(7).","DOI":"10.3390\/ijms18071414"},{"key":"12781_CR27","doi-asserted-by":"crossref","unstructured":"Khathayer F, Taylor MA, Ray SK. Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells. Apoptosis 2020, 25(3\u20134):217\u201332.","DOI":"10.1007\/s10495-020-01590-9"},{"issue":"1","key":"12781_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/CAD.0000000000001008","volume":"32","author":"MR Makena","year":"2021","unstructured":"Makena MR, Nguyen TH, Koneru B, Hindle A, Chen WH, Verlekar DU, et al. Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies. Anticancer Drugs. 2021;32(1):34\u201343.","journal-title":"Anticancer Drugs"},{"key":"12781_CR29","doi-asserted-by":"crossref","unstructured":"Li Y, Seto E. HDACs and HDAC inhibitors in Cancer Development and Therapy. Cold Spring Harb Perspect Med 2016, 6(10).","DOI":"10.1101\/cshperspect.a026831"},{"key":"12781_CR30","doi-asserted-by":"crossref","unstructured":"He Y, Yang T, Du Y, Qin L, Ma F, Wu Z, et al. High fat diet significantly changed the global gene expression profile involved in hepatic drug metabolism and pharmacokinetic system in mice. Nutr Metab (Lond). 2020 May;24:17:37.","DOI":"10.1186\/s12986-020-00456-w"},{"issue":"1","key":"12781_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1186\/s12885-020-07689-1","volume":"20","author":"X Liu","year":"2020","unstructured":"Liu X, Li T, Kong D, You H, Kong F, Tang R. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma. BMC Cancer. 2020;20(1):1204.","journal-title":"BMC Cancer"},{"issue":"1","key":"12781_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","volume":"23","author":"L Di","year":"2021","unstructured":"Di L, Balesano A, Jordan S, Shi SM. The role of Alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation. Aaps j. 2021;23(1):20.","journal-title":"Aaps j"},{"key":"12781_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang XY, et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100.","journal-title":"Cancer Lett"},{"issue":"1","key":"12781_CR34","doi-asserted-by":"publisher","first-page":"9897","DOI":"10.1038\/s41598-020-66048-z","volume":"10","author":"R Hibberd","year":"2020","unstructured":"Hibberd R, Golovina E, Farrow S, O\u2019Sullivan JM. Genetic variants associated with alcohol dependence co-ordinate regulation of ADH genes in gastrointestinal and adipose tissues. Sci Rep. 2020;10(1):9897.","journal-title":"Sci Rep"},{"issue":"2","key":"12781_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1369-1600.2010.00236.x","volume":"16","author":"UW Preuss","year":"2011","unstructured":"Preuss UW, Ridinger M, Rujescu D, Samochowiec J, Fehr C, Wurst FM, et al. Association of ADH4 genetic variants with alcohol dependence risk and related phenotypes: results from a larger multicenter association study. Addict Biol. 2011;16(2):323\u201333.","journal-title":"Addict Biol"},{"key":"12781_CR36","doi-asserted-by":"publisher","first-page":"994259","DOI":"10.3389\/fimmu.2022.994259","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Front Immunol. 2022;13:994259.","journal-title":"Front Immunol"},{"issue":"12","key":"12781_CR37","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/genes13122254","volume":"13","author":"SH Karunakara","year":"2022","unstructured":"Karunakara SH, Puttahanumantharayappa LD, Sannappa Gowda NG, Shiragannavar VD, Santhekadur PK. Novel insights into MEG3\/miR664a-3p\/ADH4 Axis and its possible role in Hepatocellular Carcinoma from an in Silico Perspective. Genes (Basel). 2022;13(12):2254.","journal-title":"Genes (Basel)"},{"issue":"1","key":"12781_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12935-023-03097-0","volume":"23","author":"D Li","year":"2023","unstructured":"Li D, Lin X, Li J, Liu X, Zhang F, Tang W, et al. Eleven metabolism-related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCC. Cancer Cell Int. 2023;23(1):277.","journal-title":"Cancer Cell Int"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12781-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:04:08Z","timestamp":1724655848000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12781-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12781"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12781-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The utilization and protocol of animals were approved by the Experimental Animal Ethics Committee of Hubei University of Medicine (No: 2021-089, provided in the Supplement Material 1). All methods were carried out in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1049"}}